Skip to main content
Supplement ScienceSupplementScience

AREDS2 Formula Side Effects & Safety

Evidence:Strong
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Safety Profile

Overall safety rating: Safe with Caution

Potential Side Effects

  • Gastrointestinal upset from high-dose zinc (80 mg)
  • Urinary tract issues reported in some participants in the AREDS trials
  • Copper supplementation required to prevent zinc-induced copper deficiency
  • Skin yellowing at high carotenoid intake (harmless)
  • Mild nausea in some individuals

Drug & Supplement Interactions

  • Zinc may interfere with certain antibiotics (tetracyclines, quinolones) — separate by 2 hours
  • High-dose vitamin E may interact with blood thinners (warfarin)
  • Zinc competes with copper and iron absorption — copper is included to offset this
  • Proton pump inhibitors may reduce zinc absorption

Maximum Dose

Do not exceed: Follow the standard AREDS2 dosage; zinc at 80 mg is already near the upper tolerable limit (40 mg UL, though 80 mg was well-tolerated in the trial)

Full AREDS2 Formula Guide

References

  1. RCTAge-Related Eye Disease Study 2 Research Group (2013). Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. DOI PubMed
  2. RCTChew EY, Clemons TE, Agrón E, et al. (2022). Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. JAMA Ophthalmology. DOI PubMed
  3. RCTAge-Related Eye Disease Study Research Group (2001). A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8. Archives of Ophthalmology. DOI PubMed